POEMS Syndrome Complicated by Extensive Calciphylaxis: A Remarkable Recovery.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25775638)

Published in J Cutan Med Surg on March 11, 2015

Authors

Emilie Bourgeault, Alice Dahl, Marie-Marthe Thibeault, Audrey Dupéré, Anne-Marie Drolet, Jean Mathieu

Articles by these authors

Measuring participation in children with disabilities using the Assessment of Life Habits. Dev Med Child Neurol (2007) 1.93

Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol (2012) 1.80

Predictors of disrupted social participation in myotonic dystrophy type 1. Arch Phys Med Rehabil (2008) 1.51

The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat Genet (2002) 1.51

Epidemiological surveillance of amyotrophic lateral sclerosis in Saguenay region. Can J Neurol Sci (2013) 1.42

Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy. Ann Neurol (2005) 1.29

Genes, maternal smoking, and the offspring brain and body during adolescence: design of the Saguenay Youth Study. Hum Brain Mapp (2007) 1.19

Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians. Neuromuscul Disord (2008) 1.05

Hereditary motor and sensory neuropathy with agenesis of the corpus callosum. Ann Neurol (2003) 1.05

Sleep complaints in patients with myotonic dystrophy. J Sleep Res (2004) 0.99

Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy. Can J Cardiol (2009) 0.98

Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial. Clin Ther (2012) 0.98

Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster. Neuromuscul Disord (2008) 0.86

Towards an integrative approach to the management of myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry (2007) 0.85

Prevalence of lifestyle risk factors in myotonic dystrophy type 1. Can J Neurol Sci (2013) 0.83

Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromuscul Disord (2009) 0.81

Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol (2013) 0.81

C9orf72 hexanucleotide repeat expansions as the causative mutation for chromosome 9p21-linked amyotrophic lateral sclerosis and frontotemporal dementia. Arch Neurol (2012) 0.81

Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. Mov Disord (2013) 0.79

Life habits in myotonic dystrophy type 1. J Rehabil Med (2007) 0.79

DOK7 mutations presenting as a proximal myopathy in French Canadians. Neuromuscul Disord (2010) 0.78

Standardized finger-nose test validity for coordination assessment in an ataxic disorder. Can J Neurol Sci (2004) 0.77

The potential of disease management for neuromuscular hereditary disorders. Rehabil Nurs (2009) 0.77

[Severe neuropathy with agenesis of the corpus callosum]. Med Sci (Paris) (2003) 0.77

Psychosocial impact of predictive testing for myotonic dystrophy type 1. Am J Med Genet A (2004) 0.77

Anticipation in myotonic dystrophy type 1 parents with small CTG expansions. Am J Med Genet A (2015) 0.76

Measurement of participation in myotonic dystrophy: reliability of the LIFE-H. Neuromuscul Disord (2006) 0.76

Intergenerational contraction of the CTG repeats in 2 families with myotonic dystrophy type 1. Neurology (2009) 0.76

Presence of palmar xanthomas in myotonic dystrophy identifies different patterns of linkage disequilibrium between the apolipoprotein E and myotonic dystrophy protein kinase loci. Genet Med (2005) 0.75

Stanford Chronic Disease Self-Management Program in myotonic dystrophy: New opportunities for occupational therapists: Stanford Chronic Disease Self-Management Program dans la dystrophie myotonique : De nouvelles opportunités pour les ergothérapeutes. Can J Occup Ther (2016) 0.75

Fine mapping the candidate region for peripheral neuropathy with or without agenesis of the corpus callosum in the French Canadian population. Eur J Hum Genet (2002) 0.75

Capecitabine-induced inflammation of actinic keratosis: case report and literature review. J Cutan Med Surg (2012) 0.75

Autosomal recessive spastic ataxia of Charlevoix-Saguenay: upper extremity aptitudes, functional independence and social participation. Int J Rehabil Res (2004) 0.75

An approach to the treatment of vulvar lymphedema. J Cutan Med Surg (2011) 0.75

Role for the central motor system in fibromyalgia: pain resolution after pontine infarction. Joint Bone Spine (2009) 0.75